This Extension of Time was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on February 10, 2023 and assigned serial number 97282621 by the TTAB.

Plaintiff:
Bioverativ Therapeutics Inc. represented by RICHARD LEHV of FROSS ZELNICK LEHRMAN & ZISSU, P.C..

Defendant:
Allyx Therapeutics, Inc. represented by DAVID EWEN of SHIPMAN & GOODWIN LLP.
Trademark Information: ALLYX THERAPEUTICS – US Trademark Serial Number 97282621
View Trademark Status at USPTO
View Trademark Documents at USPTO

Prosecution History:
February 10, 2023 – FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE
February 10, 2023 – EXT GRANTED
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.